stoxline Quote Chart Rank Option Currency Glossary
Profound Medical Corp. (PROF)
10.9174  0.247 (2.32%)    12-01 15:59
Open: 10.63
High: 10.99
Volume: 9,689
Pre. Close: 10.67
Low: 10.63
Market Cap: 233(M)
Technical analysis
2023-12-01 4:22:07 PM
Short term     
Mid term     
Targets 6-month :  13.65 1-year :  15.94
Resists First :  11.68 Second :  13.65
Pivot price 10.22
Supports First :  9.43 Second :  8.03
MAs MA(5) :  10.67 MA(20) :  10.04
MA(100) :  9.82 MA(250) :  10.86
MACD MACD :  0.4 Signal :  0.3
%K %D K(14,3) :  66.7 D(3) :  61.5
RSI RSI(14): 60
52-week High :  15.48 Low :  5
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ PROF ] has closed below upper band by 27.6%. Bollinger Bands are 46% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 11.01 - 11.05 11.05 - 11.1
Low: 10.52 - 10.57 10.57 - 10.61
Close: 10.86 - 10.94 10.94 - 11.03
Company Description

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

Headline News

Mon, 13 Nov 2023
MOPH and partners mark World Diabetes Day| Gulf Times - Gulf Times

Wed, 08 Nov 2023
Profound Medical to Participate in the Stifel 2023 Healthcare ... - Yahoo Finance

Sun, 05 Nov 2023
Profound Medical Corp. (NASDAQ:PROF) Q3 2023 Earnings Call ... - Yahoo Finance

Tue, 10 Oct 2023
Profound Medical 2023 Virtual Analyst & Investor Day Agenda - Yahoo Finance

Mon, 25 Sep 2023
Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA ... - Yahoo Finance

Tue, 19 Sep 2023
Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference - Financial Post

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical Devices
Shares Out 21 (M)
Shares Float 18 (M)
Held by Insiders 4.4 (%)
Held by Institutions 40.9 (%)
Shares Short 263 (K)
Shares Short P.Month 248 (K)
Stock Financials
EPS -1.39
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.79
Profit Margin 0 %
Operating Margin -379.7 %
Return on Assets (ttm) -28.3 %
Return on Equity (ttm) -59.2 %
Qtrly Rev. Growth -15.2 %
Gross Profit (p.s.) 0.14
Sales Per Share 0.3
EBITDA (p.s.) -1.22
Qtrly Earnings Growth 0 %
Operating Cash Flow -22 (M)
Levered Free Cash Flow -16 (M)
Stock Valuations
PE Ratio -7.88
PEG Ratio 0
Price to Book value 6.07
Price to Sales 36.24
Price to Cash Flow -10.68
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android